Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Rituximab can cause skin issues, but baricitinib may help improve them.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Mitotane changes steroid breakdown, affecting cortisol availability.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

DFMO may help control hair growth and treat cancer.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Abrocitinib may effectively treat stubborn alopecia universalis.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Clofazimine effectively treated ashy dermatosis in a patient.

Most adverse reactions to the treatment were mild, with nausea being the most common.